Literature DB >> 34357334

Metabolic Profiling of Plasma in Patients with Irritable Bowel Syndrome after a 4-Week Starch- and Sucrose-Reduced Diet.

Hans Stenlund1, Clara Nilholm2,3, Elin Chorell4, Bodil Roth2,3, Mauro D'Amato5,6, Bodil Ohlsson2,3.   

Abstract

A 4-week dietary intervention with a starch- and sucrose-restricted diet (SSRD) was conducted in patients with irritable bowel syndrome (IBS) to examine the metabolic profile in relation to nutrient intake and gastrointestinal symptoms. IBS patients were randomized to SSRD intervention (n = 69) or control continuing with their ordinary food habits (n = 22). Food intake was registered and the questionnaires IBS-symptoms severity scale (IBS-SSS) and visual analog scale for IBS (VAS-IBS) were completed. Metabolomics untargeted analysis was performed by gas chromatography mass spectrometry (GC-MS) and liquid chromatography mass spectrometry (LC-MS) in positive and negative ionization modes. SSRD led to marked changes in circulating metabolite concentrations at the group level, most prominent for reduced starch intake and increased polyunsaturated fat, with small changes in the control group. On an individual level, the correlations were weak. The marked reduction in gastrointestinal symptoms did not correlate with the metabolic changes. SSRD was observed by clear metabolic effects mainly related to linoleic acid metabolism, fatty acid biosynthesis, and beta-oxidation.

Entities:  

Keywords:  IBS; dietary advice; metabolic profiling; metabolomics; starch; sucrose

Year:  2021        PMID: 34357334     DOI: 10.3390/metabo11070440

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


  37 in total

1.  Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention.

Authors:  Hamid Noorbakhsh; Masoud Yavarmanesh; Seyed Ali Mortazavi; Peyman Adibi; Ali A Moazzami
Journal:  Eur J Nutr       Date:  2018-11-03       Impact factor: 5.614

2.  Decreased PDH activation and glycogenolysis during exercise following fat adaptation with carbohydrate restoration.

Authors:  Trent Stellingwerff; Lawrence L Spriet; Matthew J Watt; Nicholas E Kimber; Mark Hargreaves; John A Hawley; Louise M Burke
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-09-27       Impact factor: 4.310

3.  Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.

Authors:  C Tana; Y Umesaki; A Imaoka; T Handa; M Kanazawa; S Fukudo
Journal:  Neurogastroenterol Motil       Date:  2009-11-10       Impact factor: 3.598

4.  SMPDB 2.0: big improvements to the Small Molecule Pathway Database.

Authors:  Timothy Jewison; Yilu Su; Fatemeh Miri Disfany; Yongjie Liang; Craig Knox; Adam Maciejewski; Jenna Poelzer; Jessica Huynh; You Zhou; David Arndt; Yannick Djoumbou; Yifeng Liu; Lu Deng; An Chi Guo; Beomsoo Han; Allison Pon; Michael Wilson; Shahrzad Rafatnia; Philip Liu; David S Wishart
Journal:  Nucleic Acids Res       Date:  2013-11-06       Impact factor: 16.971

Review 5.  New insights into the interaction of carbohydrate and fat metabolism during exercise.

Authors:  Lawrence L Spriet
Journal:  Sports Med       Date:  2014-05       Impact factor: 11.136

6.  Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients.

Authors:  Clara Nilholm; Ewa Larsson; Bodil Roth; Rita Gustafsson; Bodil Ohlsson
Journal:  Nutrients       Date:  2019-06-05       Impact factor: 5.717

Review 7.  Metabolomics in Central Sensitivity Syndromes.

Authors:  Joseph S Miller; Luis Rodriguez-Saona; Kevin V Hackshaw
Journal:  Metabolites       Date:  2020-04-24

8.  Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS).

Authors:  Mariette Bengtsson; Bodil Ohlsson; Kerstin Ulander
Journal:  BMC Gastroenterol       Date:  2007-05-03       Impact factor: 3.067

9.  Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.

Authors:  Wen-Xue Zhang; Yu Zhang; Geng Qin; Kai-Min Li; Wei Wei; Su-Yun Li; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2019-11-21       Impact factor: 5.742

10.  The propionic acid and butyric acid in serum but not in feces are increased in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Zhenyi Tian; Xiaojun Zhuang; Mei Luo; Wei Yin; Lishou Xiong
Journal:  BMC Gastroenterol       Date:  2020-03-16       Impact factor: 3.067

View more
  4 in total

1.  Different Dose of Sucrose Consumption Divergently Influences Gut Microbiota and PPAR-γ/MAPK/NF-κB Pathway in DSS-Induced Colitis Mice.

Authors:  Xuejiao Zhang; Bowei Zhang; Bo Peng; Jin Wang; Yaozhong Hu; Ruican Wang; Shuo Wang
Journal:  Nutrients       Date:  2022-07-04       Impact factor: 6.706

2.  A Starch- and Sucrose-Reduced Diet in Irritable Bowel Syndrome Leads to Lower Circulating Levels of PAI-1 and Visfatin: A Randomized Controlled Study.

Authors:  Bodil Roth; Julia Myllyvainio; Mauro D'Amato; Ewa Larsson; Bodil Ohlsson
Journal:  Nutrients       Date:  2022-04-19       Impact factor: 6.706

3.  A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.

Authors:  Clara Nilholm; Lokeshwaran Manoharan; Bodil Roth; Mauro D'Amato; Bodil Ohlsson
Journal:  United European Gastroenterol J       Date:  2022-04-28       Impact factor: 6.866

4.  Poor intake of vitamins and minerals is associated with symptoms among patients with irritable bowel syndrome.

Authors:  Bodil Roth; Ewa Larsson; Bodil Ohlsson
Journal:  J Gastroenterol Hepatol       Date:  2022-04-05       Impact factor: 4.369

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.